The goal of this initiative is to encourage the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging to study the pathophysiology and treatment of brain disorders.
from NIMH News Feed http://bit.ly/319KB59
Tuesday, June 4, 2019
Concept Clearance » Renewal of the Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders
Concept Clearance » Renewal of the Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders
Reviewed by Unknown
on
8:45 AM
Rating: 5
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment